1. Home
  2. BEAM vs MLNK Comparison

BEAM vs MLNK Comparison

Compare BEAM & MLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • MLNK
  • Stock Information
  • Founded
  • BEAM 2017
  • MLNK 1998
  • Country
  • BEAM United States
  • MLNK United States
  • Employees
  • BEAM N/A
  • MLNK N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • MLNK Computer Software: Prepackaged Software
  • Sector
  • BEAM Health Care
  • MLNK Technology
  • Exchange
  • BEAM Nasdaq
  • MLNK Nasdaq
  • Market Cap
  • BEAM 1.9B
  • MLNK 1.8B
  • IPO Year
  • BEAM 2020
  • MLNK 2021
  • Fundamental
  • Price
  • BEAM $23.58
  • MLNK $22.41
  • Analyst Decision
  • BEAM Buy
  • MLNK Hold
  • Analyst Count
  • BEAM 11
  • MLNK 6
  • Target Price
  • BEAM $45.90
  • MLNK $23.50
  • AVG Volume (30 Days)
  • BEAM 1.3M
  • MLNK 414.1K
  • Earning Date
  • BEAM 11-05-2024
  • MLNK 11-07-2024
  • Dividend Yield
  • BEAM N/A
  • MLNK N/A
  • EPS Growth
  • BEAM N/A
  • MLNK N/A
  • EPS
  • BEAM N/A
  • MLNK N/A
  • Revenue
  • BEAM $349,643,000.00
  • MLNK $311,440,000.00
  • Revenue This Year
  • BEAM N/A
  • MLNK $6.10
  • Revenue Next Year
  • BEAM $6.04
  • MLNK $7.83
  • P/E Ratio
  • BEAM N/A
  • MLNK N/A
  • Revenue Growth
  • BEAM 328.73
  • MLNK 3.96
  • 52 Week Low
  • BEAM $20.84
  • MLNK $16.49
  • 52 Week High
  • BEAM $49.50
  • MLNK $25.88
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 45.28
  • MLNK 49.36
  • Support Level
  • BEAM $23.67
  • MLNK $21.50
  • Resistance Level
  • BEAM $25.87
  • MLNK $22.26
  • Average True Range (ATR)
  • BEAM 2.23
  • MLNK 0.80
  • MACD
  • BEAM -0.24
  • MLNK -0.18
  • Stochastic Oscillator
  • BEAM 19.58
  • MLNK 24.46

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About MLNK MeridianLink Inc.

MeridianLink Inc is a cloud-based software solution for financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. It generates maximum revenue from Lending Software Solutions.

Share on Social Networks: